Glenmark launches FDC of Teneligliptin + Pioglitazone + Metformin
The triple FDC will help improve glycemic control among adults with High HbA1c and high insulin resistance, those whose diabetes…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
pioglitazone
Successive drug launches will drive growth of NASH market in seven major markets: GlobalData
The NASH market will undergo a very rapid growth, at a compound annual growth rate (CAGR) of 68.8 per cent from 2019 to 2029